|1.||Jung-Cook, Helgi: 2 articles (02/2012 - 04/2009)|
|2.||Takayanagui, O M: 2 articles (10/2004 - 02/2002)|
|3.||Lanchote, V L: 2 articles (10/2004 - 02/2002)|
|4.||Bharkad, Gopal P: 1 article (10/2015)|
|5.||Shinde, Rajshree L: 1 article (10/2015)|
|6.||Devarajan, Padma V: 1 article (10/2015)|
|7.||Cumino, Andrea C: 1 article (01/2015)|
|8.||Loos, Julia A: 1 article (01/2015)|
|9.||Staňková, Petra: 1 article (10/2013)|
|10.||Oryan, Ahmad: 1 article (10/2013)|
|1.||Echinococcosis (Hydatid Cysts)
01/01/2000 - "Albendazole sulfoxide injection as a scolecidal agent in the percutaneous treatment of cystic echinococcosis seems to be effective in this animal model. "
10/01/2013 - "In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst."
01/01/2015 - "granulosus, as well as the in vitro synergic therapeutic effects observed in presence of Met plus albendazole sulfoxide (ABZSO), suggest the importance of carrying out chemoprophylactic and clinical efficacy studies combining Met with conventional anti-echinococcal agents to test the potential use of this drug in hydatidosis therapy. "
01/01/1988 - "[Study of the distribution of albendazole sulfoxide by liquid chromatography in plasma and cyst fluid in hydatidosis]."
09/01/2011 - "These effects were compared with those of albendazole sulfoxide (800 µg/ml), a commonly used treatment drug for hydatidosis. "
06/01/2005 - "To determine the plasmatic and intracystal concentrations of albendazole sulfoxide (AS) and correlate them with the viability of the scolices in patients surgically treated for hepatic hydatid cysts (HHC) that received albendazole preoperatively, as an indirect way of evaluating the scolicide efficacy of the drug. "
01/01/1999 - "Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis."
06/01/2002 - "Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis."
01/01/1999 - "The enantioselectivity of the kinetic disposition of albendazole sulfoxide (ASOX) was investigated in 18 patients with neurocysticercosis treated with a multiple dose regimen of albendazole for 8 days (5 mg/kg every 8 h). "
02/01/1997 - "Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone."
10/01/2015 - "Intranasal Microemulsions (MEs) for nose to brain delivery of a novel combination of Albendazole sulfoxide (ABZ-SO) and Curcumin (CUR) for Neurocysticercosis (NCC), a brain infection are reported. "
10/01/2013 - "The cysts in the animals which received albendazole sulfoxide loaded SLN every 48 h showed more ultrastructural modification. "
02/14/2006 - "Results favored a higher dose, with larger cyst reduction on MRI at 90 and 180 days and higher albendazole sulfoxide levels in plasma. "
06/01/2004 - "We investigated the minimum exposure times of prazicuantel (PZQ) and albendazole sulfoxide (ABZSO) required for their activities against Taenia cysts in vitro as well as the 50 and 99% effective concentrations. "
01/01/2001 - "granulosus tissue wet weight, histopathological examination of the cysts by both light microscopy and electron-microscopy, and the content of albendazole-sulfoxide in cysts detected by HPLC. "
04/12/1985 - "Serum and cyst concentrations of albendazole sulfoxide (the principal metabolite) have been measured."
|5.||Ovarian Neoplasms (Ovarian Cancer)
|5.||Cytochrome P-450 Enzyme System (Cytochrome P450)